Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists.
Saved in:
| Title: | Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists. |
|---|---|
| Authors: | Goldenberg RM; LMC Diabetes & Endocrinology, Concord, Ontario, Canada., Gilbert JD; Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Manjoo P; Department of Endocrinology, University of British Columbia, and Cardiometabolic Collaborative Clinic, Vancouver Island Health Authority, Vancouver, British Columbia, Canada., Pedersen SD; C-ENDO Diabetes & Endocrinology Clinic Calgary, Calgary, Alberta, Canada., Woo VC; Section of Endocrinology, Health Sciences Centre, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Lovshin JA; Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada. |
| Source: | Obesity reviews : an official journal of the International Association for the Study of Obesity [Obes Rev] 2024 Mar; Vol. 25 (3), pp. e13663. Date of Electronic Publication: 2023 Nov 15. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Blackwell Publishing Country of Publication: England NLM ID: 100897395 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1467-789X (Electronic) Linking ISSN: 14677881 NLM ISO Abbreviation: Obes Rev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1467-789X |
|---|---|
| DOI: | 10.1111/obr.13663 |
